Author, Subjects, Keywords

Cited Author

 

 
   » By Author or Editor
 » Browse Author by Alphabet
 » By Journal
 » By Subjects
 » Malaysian Journals
 » By Type
 » By Year
 » By Latest Additions
 
 
   » By Author
 » Top 20 Authors
 » Top 20 Article
 » Top Journal Cited
 » Top Article Cited
 » Journal Citation Statistics
 » Usage Since Sept 2007


 
 
 

Login | Create Account

Isolation of Human Surfactant Protein A from Amniotic Fluid

Cheong, K.B., and Cheong, S.,K., and Boo, N.Y., and Jemilah M, and Ton, S.H., (1995) Isolation of Human Surfactant Protein A from Amniotic Fluid. Malaysian Journal of Pathology, 17 (2). pp. 97-101. ISSN 0126-8635

Full text not available from this repository.

Official URL: http://www.mjpath.org.my/past_issue/MJP1995.2/isolation%20of%20human%20surfactant%20protein%20A%20from%20amniotic%20fluid.pdf

Affiliations

Universiti Kebangsaan Malaysia, Faculty of Medicine. Dept. of Pathology["lib/metafield:join_corp_creators" not defined]Universiti Kebangsaan Malaysia, Faculty of Medicine. Dept. of Pathology["lib/metafield:join_corp_creators" not defined]Universiti Kebangsaan Malaysia, Faculty of Medicine. Dept. of Paediatrics["lib/metafield:join_corp_creators" not defined]Universiti Kebangsaan Malaysia, Faculty of Medicine. Dept. of Obstetrics and Gynecology["lib/metafield:join_corp_creators" not defined]Universiti Kebangsaan Malaysia, Faculty of Medicine. Dept. of Biochemistry

Abstract

Surfactant protein A (SP-A) is one of the four known surfactant-associated proteins found in human lungs. It plays a major role in determining regulation of surfactant uptake and resecretion. Qualitative and quantitative deficiencies of SP-A may contribute to neonatal respiratory distress syndrome. The measurement of its level in amniotic fluid or neonatal tracheal aspirate may be useful in the assessment of replacement therapy using natural or synthetic surfactants. In order to develop an in-house immunoassay to detect the level of SP-A, we used a discontinuous sucrose density gradient to isolate SP-A from amniotic fluid. Polyacrylamide gel electrophoresis was carried out on the isolates with low molecular weight markers. We successfully isolated SP-A from 12 out of 31 samples of amniotic fluid. The isolates were found to be relatively pure and have a molecular weight of about 35 kD. The isolated SP-A were used as immunogens to raise antibodies in rabbits for the immunoassay .

Item Type:Journal
Additional Information:This note was added by the search_and_modify.pl script.
Keywords:SP-A, respiratory distress syndrome, polyacrylamide gel electrophoresis, sucrose density gradient.
Subjects:R Medicine, Dentistry, Pharmacy, Nursing
ID Code:3589

1. King W, Clements JA. Surface active materials from dog lung. II Complication and physiological correlations. J Appl Physiol 1972; 223 : 715-21.

2. Van Golde LMG, Batenburg JJ, Robertson B. The pulmonary surfactant system : biochemical aspects and physiological significance. Physiol Rev 1988; 68 : 374-9.

3. Yu SH, Prossmayer F. Role of bovine pulmonary surfactant-associated proteins in the surface active property of phospholipid mixtures. Biochirn Biophys Acta 1990; 1046 : 233-41.

4. Hawgood S, Benson BJ, Schilling J, Damm D. Nucleotide and amino acid sequences of pulmonary surfactant protein SP-18 and evidence for cooperation between SP-l8 and SP 26-36 in surfactant lipid absorption. Proc Natl Acad Sci U.S.A. 1987; 85 : 66-70.

5. Avery ME, Mead J. Surface properties in relation to atelectasis and hyaline membrane disease. Am J Dis Child 1959; 97 : 517-23.

6. Milner AD. Archives of disease in childhood. J Br Ped Ass 1993; 68 : 253-4.

7. Dunn MS. Surfactant replacement therapy. : prophylaxis or treatment? Pediatrics 1993; 92 : 148-50.

8. Gormally SM, Clarke TA, Krishnan A, Ali M, Matthews TG. Surfactant therapy in respiratory distress syndrome : the effect of a leaning curve in improving outcome. Iri J Med Sci 1993, 162 (1 1): 458-61.

9. Hamvas A, Devine T, Cole FS. Surfactant therapy failure identifies infants at risk for pulmonary mortality. Am Rev Resp Dis 1993; 147: 665-6.

10. Hallman M, Meritte TA, Schneider H, er al. Isolation of human surfactant from amniotic fluid and a pilot study of its efficacy in respiratory syndrome. Pediatrics 1983; 71 (4) : 473-81.

11. Laemlli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T,. Nature 1970; 227 : 680-5.

12. Murphy JB, Kies MW. Peptide bond absorption in the 195 - 225 mF region. Biochim Biophys Acta 1960; 45 : 382-3.

13. Evelyn DR, Machiko I, leffrey AW, William H, Darryl A, Alan HJ. Treatment responses to surfactants containing natural surfactant proteins in pretenn rabbits. Am Rev Respir Dis 1993; 147 : 669-76.

14. Gary FR, Robert HN, Joseph M, Jeffrey AW. Phospholipid binding and biophysical activity of pulmonary surfactant-associated protein (SAP)-35 and its non-collagenous COOH-terminal domains. J Biol Chem 1986; 261 : 14283-91.

15. Frosolo MF, Roux JF. Surface-active material in human amniotic fluid. Am J Obstet Gynecol 1978; 130 : 562-6.

16. Wali A, Dhall K, Sanyal SN, Juneja R, Majundar S. Immunoassay for the determination of surfactant apoprotein (SP-A) in human amniotic fluid : comparison with other indices of assessing foetal lung maturity. Scan J Clin lab Inves 1992; 52 : 355-60.

17. Johnstone A, Thorpe R. Polyacrylamide gel techniques. In : Immunochemistry in practice. London : Blackwell Scientific Publications. 1982 : 142.

Repository Staff Only: item control page